Reference
Health Canada. Summary Safety Review - Imatinib Mesylate (GLEEVEC and generics) - Assessing the Risk of Decline in Kidney Function During Long-Term Treatment. Internet Document : 7 Mar 2016. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/gleevec-eng.php
Rights and permissions
About this article
Cite this article
Kidney function progressively declines with long-term imatinib. Reactions Weekly 1593, 2 (2016). https://doi.org/10.1007/s40278-016-15645-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-15645-7